Moderna 'advancing' 2 Omicron vax candidates against newer variants
Published: Jul 12, 2022 9:46 AM
Moderna Inc said yesterday it was advancing two Omicron vaccine candidates for the fall, one designed against the BA.1 variant and another against the BA.4 and BA.5.
Vaccine makers including Moderna and rival Pfizer Inc are developing updated vaccines to target the fast-spreading Omicron subvariants BA.4 and BA.5, which have gained a foothold in the United States over recent weeks.
Moderna said its decision to...
View Comments0
Report this comment
500 characters remaining






Are you sure you want to delete this comment?
This action cannot be undone.